Ophthalmology – Visual Hallucinations

Basics

Description

Visual hallucinations are visual perceptions that occur without a corresponding external visual stimulus. They are not a diagnosis by themselves, but rather a symptom that may arise from ophthalmic, neurologic, metabolic, toxic, medication-related, or psychiatric conditions.

Hallucinations may be simple, such as flashes, colored lights, sparkles, geometric shapes, or patterns, or complex, such as seeing people, animals, faces, flowers, or complete scenes.

An especially important ophthalmic form is Charles Bonnet syndrome (CBS). In CBS, patients with significant visual impairment experience vivid, often complex visual hallucinations while retaining insight that the images are not real. Cognition is otherwise relatively preserved.

Epidemiology

The frequency of visual hallucinations varies considerably depending on the patient population and underlying disorder.

They are common in patients with dementia, delirium, metabolic encephalopathy, severe visual impairment, and certain neurologic disorders.

Among ophthalmic populations, visual hallucinations are particularly associated with older age and substantial reduction in visual acuity. Charles Bonnet syndrome is probably underrecognized because many patients are reluctant to report hallucinations for fear of being considered psychiatrically ill.

Risk Factors

Important risk factors include significant visual loss, advanced age, social isolation, dementia, psychiatric disease, alcohol or illicit drug use, medication exposure, and metabolic illness.

Women have been reported to experience visual hallucinations somewhat more frequently in some populations.

Pathophysiology

The mechanism depends on the underlying cause.

In patients with severe visual impairment, reduced sensory input to the visual cortex may produce a release phenomenon or deafferentation phenomenon. Normally, continuous external visual input suppresses internally generated visual imagery. When visual input is markedly reduced, previously suppressed visual cortical activity may emerge as hallucinations.

This mechanism is believed to contribute to Charles Bonnet syndrome.

In epilepsy, abnormal electrical activity affecting the occipital or temporal cortex can produce ictal visual hallucinations.

Migraine aura is related to cortical spreading depression, a wave of neuronal activation followed by suppression that commonly spreads through the visual cortex.

Hallucinogenic drugs and other toxic agents may alter serotonergic, limbic, and cortical pathways.

Etiology

Visual hallucinations can arise from several major categories of disease.

Ophthalmic Causes

Severe visual impairment from conditions such as advanced cataract, glaucoma, retinal disease, optic neuropathy, or loss of an eye can produce release hallucinations and Charles Bonnet syndrome.

Neurologic Causes

Neurologic causes include epilepsy, migraine, narcolepsy, Parkinson disease, Alzheimer disease, dementia with Lewy bodies, brainstem disease, thalamic disease, occipital or temporal lobe lesions, stroke, and other structural brain disorders.

Toxic and Metabolic Causes

Hallucinations may occur with drug intoxication, medication adverse effects, alcohol intoxication or withdrawal, metabolic encephalopathy, hypoxia, organ failure, and delirium.

Psychiatric Causes

Psychotic illnesses such as schizophrenia can include visual hallucinations, although auditory hallucinations are more typical.

Commonly Associated Conditions

Important associations include visual deprivation, dementia, Parkinson disease, dementia with Lewy bodies, delirium, delirium tremens, psychosis, substance use, medication toxicity, seizures, and migraine.

Diagnosis

History

A detailed description of the visual experience is essential.

Patients should be asked about:

• What exactly they see
• Whether the images are formed or unformed
• Whether the images move
• How long they last
• How often they occur
• Whether they affect one or both visual fields
• Whether they occur with eyes open, closed, or both
• Whether the patient knows the images are not real
• Associated headache, weakness, confusion, seizure activity, sleep disturbance, or other neurologic symptoms
• Visual impairment or recent worsening of vision
• Current medications
• Alcohol and illicit drug use
• Recent withdrawal from alcohol or other substances

Patients may avoid mentioning hallucinations unless asked directly because they fear being labeled as mentally ill.

That makes direct, nonjudgmental questioning especially important in patients with significant visual impairment or dementia.

Physical Examination

A full ophthalmic and neurologic examination is appropriate.

The eye examination should include visual acuity, pupillary responses, visual fields, ocular motility, anterior segment examination, and fundus examination.

The neurologic examination should assess mental status, cranial nerves, motor function, sensation, coordination, gait, and signs of focal neurologic disease.

Diagnostic Tests and Interpretation

Testing should be directed by the suspected cause rather than performed routinely in every patient.

Laboratory Testing

When toxic or metabolic disease is suspected, laboratory testing may include metabolic studies, toxicology testing, medication levels, and other investigations guided by the clinical presentation.

Electroencephalography

EEG may be useful when seizure activity or encephalopathy is suspected.

Brief, stereotyped, recurrent hallucinations, particularly when accompanied by altered awareness or other seizure manifestations, increase suspicion for an epileptic cause.

Neuroimaging

MRI of the brain is appropriate when a structural brainstem, thalamic, temporal, or occipital lesion is suspected.

Acute presentations may require urgent neuroimaging depending on associated neurologic findings.

Differential Diagnosis

Visual hallucinations must be distinguished from several related phenomena.

Delusions

A delusion is a fixed false belief that the patient believes to be true. It is not a sensory perception.

Confabulation

Confabulation refers to fabricated or distorted memories, often occurring in patients with memory impairment.

Visual Illusions

An illusion is a distorted perception of something that is actually present.

Examples include metamorphopsia, polyopia, palinopsia, or misinterpretation of real objects.

Hallucinations

A hallucination occurs when a person sees something without any corresponding external object.

Simple Visual Hallucinations

Simple hallucinations consist of elementary visual phenomena such as:

flashes, sparkles, colored lights, geometric shapes, patterns, halos, or phosphenes.

They are more often associated with occipital cortex dysfunction, migraine, retinal disease, or seizure activity.

Complex Visual Hallucinations

Complex hallucinations include formed images such as:

people, animals, faces, buildings, flowers, or complete scenes.

They may occur with Charles Bonnet syndrome, temporal lobe disorders, dementia, delirium, or brainstem disease.

Charles Bonnet Syndrome

Charles Bonnet syndrome consists of recurrent, often vivid and detailed visual hallucinations occurring in a person with significant visual impairment but without primary psychosis or major cognitive impairment.

Patients typically retain insight and recognize that the images are not actually present.

The hallucinations are often nonthreatening and may include people, animals, buildings, patterns, or scenery.

CBS is associated with a wide range of causes of reduced vision, including macular degeneration, glaucoma, cataract, diabetic eye disease, retinal degeneration, and optic neuropathy.

Reassurance is especially important because many patients fear that hallucinations indicate dementia or psychiatric illness.

Ictal Hallucinations

Visual hallucinations caused by seizures tend to be brief, stereotyped, and recurrent.

Occipital seizures usually produce simple unformed visual phenomena, whereas temporal lobe seizure activity is more likely to produce complex formed images.

Peduncular Hallucinosis

Peduncular hallucinosis consists of vivid, colorful, often highly detailed visual hallucinations associated with lesions involving the midbrain, pons, or thalamus.

Patients may maintain insight.

The mechanism is thought to involve disruption of pathways regulating visual sensory processing and arousal.

Migraine Aura

Migraine aura frequently causes transient visual phenomena such as:

flashing lights, scintillating scotomas, zigzag lines, fortification patterns, or expanding areas of visual disturbance.

These phenomena usually evolve over minutes rather than appearing instantaneously.

Alice in Wonderland Syndrome

Alice in Wonderland syndrome is a rare perceptual disturbance often associated with migraine, particularly in children.

Patients may experience metamorphopsia, altered body image, changes in perceived object size, or distortion of spatial relationships and perspective.

Hypnagogic Hallucinations

Hypnagogic hallucinations occur while a person is falling asleep.

They can be vivid and dreamlike and are particularly associated with narcolepsy, although they can occur in otherwise healthy individuals.

Dementia-Related Hallucinations

Visual hallucinations are common in several neurodegenerative disorders.

They are especially characteristic of dementia with Lewy bodies, where recurrent detailed visual hallucinations may occur together with progressive cognitive impairment, fluctuating attention, parkinsonism, and REM sleep behavior disorder.

Patients with Lewy body dementia can be highly sensitive to antipsychotic medications, an important management consideration.

Visual hallucinations also occur in Parkinson disease and Alzheimer disease.

Pediatric Considerations

In children, possible causes include seizures, migraine, sleep disorders, medication effects, substance exposure, psychiatric disease, and night terrors.

Alice in Wonderland syndrome is particularly associated with childhood migraine.

A careful neurologic and medication history is important.

Geriatric Considerations

Older adults may experience visual hallucinations because of visual impairment, dementia, delirium, medication toxicity, Parkinson disease, or Lewy body dementia.

Seeing people, animals, or detailed scenes is particularly common in both Charles Bonnet syndrome and dementia-associated hallucinations.

Distinguishing between these conditions requires assessment of cognition, insight, visual function, and neurologic status.

Treatment

Treatment depends entirely on the underlying cause.

There is no single medication appropriate for all visual hallucinations.

Charles Bonnet Syndrome Treatment

The main treatments for CBS are reassurance and optimization of vision.

Patients should be told that the hallucinations can occur as a consequence of visual deprivation and do not by themselves imply psychosis or dementia.

Correctable causes of visual impairment should be treated when possible.

Improving environmental lighting, increasing social engagement, and changing visual fixation or blinking may sometimes interrupt episodes.

Medication is rarely required unless hallucinations are persistent and severely distressing.

Seizure-Related Hallucinations

Hallucinations caused by epilepsy should be treated with appropriate antiseizure therapy under neurologic supervision.

Migraine

Migraine-associated visual phenomena are treated according to standard migraine management when attacks are frequent or disabling.

Delirium and Metabolic Disease

When hallucinations occur in delirium or metabolic encephalopathy, the priority is correction of the underlying medical abnormality.

Potential causes include infection, electrolyte disturbance, organ failure, hypoxia, medication toxicity, or withdrawal states.

Psychiatric Disease

Antipsychotic treatment may be appropriate when hallucinations arise from psychotic illness, severe agitation, or certain dementia syndromes.

Medication choice must be individualized according to the patient’s diagnosis, previous treatment response, comorbidities, potential drug interactions, and adverse-effect profile.

Dementia With Lewy Bodies

Mild hallucinations that are not distressing may require no drug treatment.

Cholinesterase inhibitors may improve hallucinations and cognitive symptoms in some patients.

Extreme caution is required with antipsychotic drugs because patients with dementia with Lewy bodies can develop profound neuroleptic sensitivity, including worsening parkinsonism, altered consciousness, or potentially life-threatening reactions.

Management should therefore be coordinated with neurology, geriatrics, or psychiatry.

Referral

Referral depends on the suspected cause.

An ophthalmologist should evaluate patients with significant visual loss or suspected ocular disease.

A neurologist should evaluate suspected seizures, migraine with unusual features, structural neurologic disease, Parkinsonism, or focal neurologic findings.

A psychiatrist may be appropriate when primary psychiatric disease is suspected or hallucinations are severely distressing and require psychotropic treatment.

Inpatient Considerations

Hospitalization may be required when hallucinations occur in the setting of delirium, severe metabolic disturbance, intoxication or withdrawal, severe agitation, or dangerous behavior.

Treatment should focus on correcting the underlying metabolic or toxic abnormality and ensuring patient safety.

Patients with severe agitation require careful monitoring to prevent injury to themselves or others.

Follow-Up

Follow-up should be tailored to the underlying condition.

Medication lists should be reviewed regularly because medications can trigger or worsen hallucinations.

Patients with Charles Bonnet syndrome benefit from periodic ophthalmic follow-up to optimize remaining visual function.

Patients with neurologic or psychiatric causes require appropriate specialist follow-up.

Patient Education

Reassurance is particularly important in patients with Charles Bonnet syndrome.

Patients should be informed that visual hallucinations associated with visual impairment are a recognized neurologic response to reduced visual input.

They should also be encouraged to report hallucinations openly rather than concealing them.

New hallucinations associated with confusion, weakness, severe headache, seizure activity, fever, or sudden neurologic changes require urgent medical evaluation.

Prognosis

The prognosis depends on the underlying cause.

Hallucinations caused by a reversible metabolic or toxic abnormality may resolve when the abnormality is corrected.

Charles Bonnet hallucinations may decrease with reassurance or improved visual function, but they can persist for months or years in some patients.

Hallucinations associated with chronic neurodegenerative disorders may recur or progress over time.

Complications

Visual hallucinations themselves may cause fear, anxiety, sleep disruption, social withdrawal, or unsafe behavior.

Patients may conceal symptoms because of fear of psychiatric stigma.

In delirium or dementia, hallucinations can contribute to agitation, falls, or self-injury.

The most important clinical task is therefore to distinguish relatively benign phenomena such as Charles Bonnet syndrome from hallucinations caused by potentially serious neurologic, metabolic, toxic, or psychiatric disease.